⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for refractory or relapsed

Every month we try and update this database with for refractory or relapsed cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple MyelomaNCT02056756
Multiple Myelom...
Carfilzomib
18 Years - Stichting European Myeloma Network
Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) to Receive QuizartinibNCT03746912
Acute Myeloid L...
Quizartinib Dih...
18 Years - Daiichi Sankyo
Safety Study of Nifurtimox for Relapsed or Refractory NeuroblastomaNCT00486564
Neuroblastoma
Nifurtimox
- 21 YearsUniversity of Vermont
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: